Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
60,203,263
-
Share change
-
+8,823,817
-
Total reported value
-
$220,958,216
-
Put/Call ratio
-
25%
-
Price per share
-
$3.67
-
Number of holders
-
106
-
Value change
-
+$34,366,937
-
Number of buys
-
62
-
Number of sells
-
29
Institutional Holders of IMMUNOMEDICS INC - COM (IMMU) as of Q4 2016
As of 31 Dec 2016 IMMUNOMEDICS INC - COM (IMMU) had 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 60,203,263 shares of stock of the company.
Largest 10 holders included venBio Select Advisor LLC, ACUTA CAPITAL PARTNERS, LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, EverPoint Asset Management, LLC, BlackRock Institutional Trust Company, N.A., MILLENNIUM MANAGEMENT LLC, Tourbillon Capital Partners, L.P., and First Light Asset Management, LLC.
This table shows 106 institutional shareholders of the security as of 31 Dec 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.